Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01351389Not ApplicableCompleted

Brief Interventions in the Emergency Department for Alcohol and HIV/Sexual Risk

Role: collaborator

NCT06842875Not ApplicableRecruiting

Rhode Island - Statewide Postpartum Hypertension Remote Surveillance

Role: collaborator

NCT04188041Not ApplicableCompleted

Improving Rhode Island's Tuberculosis Preventive Services in Primary Care

Role: lead

NCT02360397Phase 2Completed

Ranolazine Mediated PVC Reduction in Ischemic Heart Disease

Role: lead

All 4 trials loaded